David Dingli, M.D., Ph.D., with Hematology at Mayo Clinic's campus in Rochester, Minnesota, discusses findings from the study Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy, which was published in the April 2017 issue of Mayo Clinic Proceedings.

Dr. Dingli updates clinicians and patients on new treatment options for this increasingly complicated disease progression.